Mettler-Toledo International Inc. (NYSE:MTD) Receives Average Rating of “Reduce” from Brokerages

Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been given a consensus recommendation of “Reduce” by the eight brokerages that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $1,338.75.

A number of equities research analysts have recently commented on the company. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Robert W. Baird cut their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Finally, Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st.

Mettler-Toledo International Stock Up 0.6 %

Shares of Mettler-Toledo International stock opened at $1,224.99 on Tuesday. The business has a fifty day simple moving average of $1,358.47 and a 200-day simple moving average of $1,399.52. The firm has a market cap of $25.85 billion, a price-to-earnings ratio of 33.03, a price-to-earnings-growth ratio of 4.02 and a beta of 1.16. Mettler-Toledo International has a fifty-two week low of $1,059.08 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Analysts anticipate that Mettler-Toledo International will post 40.39 earnings per share for the current fiscal year.

Insider Activity

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.94% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several large investors have recently made changes to their positions in MTD. PineStone Asset Management Inc. grew its position in Mettler-Toledo International by 127.4% in the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after acquiring an additional 145,453 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in Mettler-Toledo International by 149,870.0% in the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Mettler-Toledo International by 88.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after buying an additional 57,509 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after buying an additional 35,048 shares in the last quarter. Finally, Wellington Management Group LLP lifted its position in shares of Mettler-Toledo International by 17.5% in the third quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock worth $266,891,000 after buying an additional 26,443 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.